Verseau Therapeutics

1 follower


Verseau is focused on developing the next major wave of cancer immunotherapies directed at a broad and potent reprogramming of the tumor microenvironment to attack tumors.

Industries

Headquarters

Stage

Employees

Links

Org chart

Tatiana Novobrantseva
Co-Founder & Chief Scientific Officer
Karen Tubridy
Chief Development Officer
Lou Vaickus
Chief Medical Officer
Susan Low
Vice President